Trials / Terminated
TerminatedNCT01946646
Phase I Study of TS-1 With Concurrent Radiotherapy to Treat Pancreatic Cancer
A Phase I Study of TS-1 With Concurrent Radiotherapy Followed by Gemcitabine and TS-1 in Metastatic Pancreatic Cancer (SR-GS Study)
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- National Taiwan University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether combination of TS-1 and concurrent and short-course radiotherapy is feasible in metastatic pancreatic cancer. The rationale of this study primarily bases on the good efficacy of gemcitabine plus TS-1 and the great potential of local control of concurrent chemoradiotherapy in pancreatic cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | S-1-CCRT |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2017-01-01
- Completion
- 2017-01-01
- First posted
- 2013-09-19
- Last updated
- 2017-01-18
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01946646. Inclusion in this directory is not an endorsement.